NEDD4L and Miyoshi myopathy: Novel evidence recently reported by Huang et al. shows that NEDD4L favors the tumor suppressive function and involves in the drug sensitivity in the MM cancer cells, by acting as an autophagy activator (Huang et al. 2022).